Drug Characteristics
  • Formulation

    Unlicensed in UK, available from special order manufacturers.

    Tablets: 500 mg

    Suspension: 100 mg/5ml

  • Dose

    Cryptosporidium

    Orally 500 mg twice a day for 3 days but may be required for up to 12 weeks

    In trials 1g twice a day

  • Side Effects

    Abdominal pain, vomiting, diarrhoea, headache and a green tint to urine and other bodily secretions

  • Interactions

    Nitazoxanide is highly bound to plasma protein (>99.9%). Therefore, caution should be used when administering nitazoxanide concurrently with other highly plasma protein-bound drugs with narrow therapeutic indices, as competition for binding sites may occur

  • Renal

    No data available on use in patients with renal dysfunction

  • Hepatic

    No data available on use in patients with hepatic dysfunction

  • Pregnancy

    No Human Data – Animal Data Suggest Low Risk

  • Other Information